Skip to content

US · SBC · CONSULTING SERVICES

SBC Medical Group Holdings Incorporated (SBC) intrinsic value and stock valuation

$5.17as of 2026-11-21 · Mkt cap 313.68M

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

SBC Medical Group Holdings Incorporated DCF and intrinsic value

InvestorsCraft values SBC with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from SBC’s statements →

SBC Medical Group Holdings Incorporated Graham Number

Graham Number: $5.34d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Industrials · Consulting Services Irvine, CA 92618 sbc-holdings.com

How the business is doing

Fiscal 2022–2025, USD

Revenue
$173.6M
20222025
Net income
$51M
20222025
Free cash flow
$36.6M
20222025
Total equity
$263.3M
20222025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2022–2025, USD
2025202420232022
Revenue$173.6M$205.4M$193.5M$174.2M
Operating income$67.5M$70.3M$70.7M$20.1M
Net income$51M$46.6M$39.4M$6.32M
EPSd$495K$482.7K$418K$419.4K
Operating cash flow$38.9M$20.6M$50.6M-$-50K
Capital expenditure-$-2.37M-$-3.41M-$-11.21M-$-24.95M
Free cash flow$36.6M$17.2M$39.4M-$-24.99M
Total assets$380.5M$266.1M$258.8M$225.5M
Total debt$51.6M$12.2M$22.9M$16.1M
Net debt-$-112.14M-$-112.83M-$-80.16M-$-35.61M
Total equity$263.3M$195M$143.8M$107.9M
Cash and short-term investments$164.1M$125M$103M$53.6M
Income statement
2025202420232022
Revenue$173.6M$205.4M$193.5M$174.2M
Cost of revenue$46.3M$49.4M$56.2M$59.3M
Gross profit$127.3M$156.1M$137.3M$114.8M
Research and development expenses$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$58.9M$70.1M$66.2M$93.5M
Other expenses$940K$15.7M$410K$1.23M
Operating expenses$59.8M$85.8M$66.6M$94.7M
Cost and expenses$106.1M$135.1M$122.9M$154M
Interest income$200K$20K$90K$470K
Interest expense$160K$30K$50K$30K
Depreciation and amortization$2.68M$3.8M$12.3M$5.93M
Ebitda$84.9M$77.3M$85.9M$29.6M
Operating income$67.5M$70.3M$70.7M$20.1M
Total other income/expenses, net$14.6M$3.15M$2.92M$3.56M
Income before tax$82.1M$73.5M$73.6M$23.7M
Income tax expense$31M$26.8M$35M$18.1M
Net income$51M$46.6M$39.4M$6.32M
Weighted average shares outstanding$103M$96.6M$94.2M$15.1M
Weighted average diluted shares outstanding$103M$96.6M$94.2M$15.1M
Balance sheet
2025202420232022
Cash and short-term investments$164.1M$125M$103M$53.6M
Net receivables$53.1M$48.2M$53.1M$43.7M
Inventory$2.79M$1.49M$3.09M$1.35M
Total current assets$231.2M$184.5M$165.9M$113M
Property, plant and equipment, net$16.4M$14M$19.5M$21.5M
Goodwill and intangible assets$63.2M$6.2M$23.3M$11.1M
Long-term investments$58M$20.9M$20.7M$920K
Total non-current assets$149.2M$81.6M$92.9M$112.5M
Total assets$380.5M$266.1M$258.8M$225.5M
Accounts payable$17.6M$14.5M$26.5M$15.3M
Short-term debt$13.7M$4.46M$7.41M$8.24M
Deferred revenue$9.47M$12.6M$25.1M$30.4M
Total current liabilities$61.1M$61.2M$92.5M$101.3M
Long-term debt$38M$7.75M$15.5M$7.89M
Deferred revenue, non-current$0.00$0.00$0.00$0.00
Total non-current liabilities$56M$9.87M$22.5M$16.4M
Capital lease obligations$4.25M$5.58M$6.33M$5.84M
Total liabilities$117.1M$71.1M$115M$117.6M
Common stock$10K$10K$10K$0.00
Retained earnings$240.5M$189.5M$142.9M$103.5M
Accumulated other comprehensive income (loss)-$-57.29M-$-54.18M-$-37.58M-$-24.85M
Total equity$263.3M$195M$143.8M$107.9M
Total investments$58.3M$20.9M$20.7M$2.82M
Total debt$51.6M$12.2M$22.9M$16.1M
Net debt-$-112.14M-$-112.83M-$-80.16M-$-35.61M
Cash flow statement
2025202420232022
Net income$51M$46.6M$39.4M$5.55M
Depreciation and amortization$2.68M$3.8M$12.3M$5.93M
Stock-based compensation$0.00$13M$0.00$0.00
Change in working capital-$-12.28M-$-12.13M-$-7.68M-$-10.59M
Accounts receivable$4.47M$13.1M-$-6.01M-$-9.6M
Inventory-$-170K$1.12M-$-1.83M-$-670K
Accounts payable$2.67M-$-8.91M$12.2M$170K
Net cash provided by operating activities$38.9M$20.6M$50.6M-$-50K
Investments in property, plant and equipment-$-2.79M-$-3.41M-$-9.52M-$-24.95M
Acquisitions, net-$-15.46M-$-5.07M$720K-$-6.49M
Net cash used for investing activities-$-20.97M-$-10.1M$1.82M-$-32.65M
Common stock issued$0.00$30K$0.00$118.8M
Common stock repurchased-$-5M$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00
Net cash used for financing activities$24M$23M$6.14M-$-7.98M
Net change in cash$38.7M$22M$51.3M-$-52.77M
Cash at end of period$163.8M$125M$103M$51.7M
Operating cash flow$38.9M$20.6M$50.6M-$-50K
Capital expenditure-$-2.37M-$-3.41M-$-11.21M-$-24.95M
Free cash flow$36.6M$17.2M$39.4M-$-24.99M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About SBC Medical Group Holdings Incorporated

        SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company delivers a diverse array of administrative and support functions, such as orchestrating marketing and advertising campaigns, offering extensive human resources solutions including talent acquisition and staff training, and streamlining appointment scheduling for franchisee clinics. Furthermore, SBC Medical Group facilitates real estate arrangements for both employee housing and clinic facility rentals, oversees the design and construction of new clinics, and manages the procurement of essential medical equipment and supplies. Additionally, the firm furnishes IT software solutions. The broad spectrum of aesthetic and reconstructive procedures facilitated by SBC Medical Group's supported clinics encompasses both surgical and non-surgical interventions. These include popular treatments such as breast augmentation, liposuction, and various rejuvenation therapies targeting wrinkles, acne, scars, and signs of aging. The offerings also extend to specialized procedures like laser skin toning, double fold eye surgery, rhinoplasty, hair transplants, laser hair removal, cosmetic dental work, tattoo removal, and advanced eye procedures like LASIK, among others. Established in 2000, SBC Medical Group Holdings Incorporated maintains its headquarters in Irvine, California.

        CEO
        Yoshiyuki Aikawa
        Employees
        863
        Beta
        0.59

        Explore

        Frequently asked questions

        What is the intrinsic value of SBC Medical Group Holdings Incorporated (SBC)?

        SBC Medical Group Holdings Incorporated (SBC) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is SBC undervalued?

        SBC trades at a price of $5.17 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.